SCHEMBL16127947

SCHEMBL16127947

Cc1cccc(C(=O)O)c1C(=O)Nc1ccc(CCCO)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 1/20 0.49
▸ ITGB1 P05556 4/20 0.45
▸ ITGA4 P13612 4/20 0.45
▸ ITGA2 P17301 1/20 0.45
▸ ITGB7 P26010 1/20 0.45
▸ HPGD P15428 3/20 0.44
▸ SMN1; SMN2 Q16637 4/20 0.44
▸ TRPV1 Q8NER1 1/20 0.44
▸ GAA P10253 2/20 0.44
▸ TP53 P04637 1/20 0.44
▸ POLB P06746 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ CRHBP P24387 1/20 0.43
▸ FNTA P49354 1/20 0.43
▸ FNTB P49356 1/20 0.43
▸ CRHR2 Q13324 1/20 0.43
▸ ALOX15 P16050 2/20 0.43
▸ GFER P55789 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16088671 0.90 TRPV1 (0.56) FFAR1SMN1; SMN2TRPV1GAATP53
SCHEMBL17538521 0.90 FFAR1 (0.52) FFAR1ITGB1ITGA4ITGA2ITGB7
SCHEMBL16127933 0.85 ITGB1 (0.52) ITGB1ITGA4ITGA2ITGB7ALOX15
SCHEMBL16127937 0.85 PLK1 (0.46) ITGB1ITGA4SMN1; SMN2TRPV1GAA
SCHEMBL16127940 0.82 KMT2A (0.43) ITGB1ITGA4SMN1; SMN2TRPV1POLB
SCHEMBL12614440 0.81 ALDH1A1 (0.63) SMN1; SMN2TRPV1ALDH1A1ALOX15GFER
SCHEMBL22113968 0.80 FFAR1 (0.47) FFAR1ITGB1ITGA4ITGA2ITGB7
SCHEMBL16127942 0.78 MEN1 (0.49) ITGB1ITGA4SMN1; SMN2TP53POLB
SCHEMBL16127943 0.78 KLKB1 (0.52) ITGB1ITGA4SMN1; SMN2ALOX15
SCHEMBL16088641 0.77 PLK1 (0.56) SMN1; SMN2TRPV1GAATP53POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2968330-B1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS SCRIPPS RESEARCH INST (US) 2021-09-29 — — EP disclosed
US-11045476-B2 Compounds and methods for inducing chondrogenesis THE SCRIPPS RESEARCH INSTITUTE (US) 2021-06-29 — — US disclosed
US-20200188407-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS THE SCRIPPS RESEARCH INSTITUTE 2020-06-18 — — US disclosed
US-9452170-B2 Compounds and methods for inducing chondrogenesis THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2016-09-27 — — US disclosed
US-9452170-B2 Compounds and methods for inducing chondrogenesis THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2016-09-27 — — US disclosed
US-20160045514-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2016-02-18 — — US disclosed
US-20160045514-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2016-02-18 — — US disclosed
WO-2014151953-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2014-09-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11045476-B2 Compounds and methods for inducing chondrogenesis COL2A1, BMP4, COL1A1 FFAR1 2848/4885ITGB1 2770/4885ITGA4 3063/4885
US-20160045514-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS COL2A1, BMP4, COL1A1 FFAR1 2848/4885ITGB1 2770/4885ITGA4 3063/4885
US-20200188407-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS COL2A1, BMP4, COL1A1 FFAR1 2848/4885ITGB1 2770/4885ITGA4 3063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback